Literature DB >> 16183116

Chronic exposure to benzene results in a unique form of dysplasia.

Richard D Irons1, Ling Lv, Sherilyn A Gross, Xibiao Ye, Liming Bao, Xiao Qin Wang, John Ryder, Thomas W Armstrong, Yimei Zhou, Lizhaung Miao, Anh T Le, Patrick J Kerzic, Weimin Ni, Hua Fu.   

Abstract

Hematotoxicity following chronic benzene exposure has been recognized for over a century, although the mechanism remains unknown. We describe a novel form of bone marrow dysplasia in 23 workers exposed to high concentrations of benzene. Distinguishing features of benzene-induced dysplasia include: marked dyserythropoiesis, eosinophilic dysplasia and abnormal cytoplasmic granulation of neutrophilic precursors. Hematophagocytosis, stromal degeneration and bone marrow hypoplasia are also seen. Severe bone marrow dysplasia is frequently accompanied by clonal T cell expansion and alterations in T lymphocyte subsets. No clonal cytogenetic abnormalities were observed. These results suggest that autoimmune-mediated bone marrow injury is an early or predisposing event in the pathogenesis of benzene-induced persistent hematopoietic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183116     DOI: 10.1016/j.leukres.2005.08.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

Review 1.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

2.  Temozolomide-induced myelodysplasia.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2010-03-04

3.  Lymphoreticular diseases in Nigerians.

Authors:  Kayode A Adelusola; Donatus O Sabageh; Cornelius O Ukah
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

4.  The vanishing zero revisited: thresholds in the age of genomics.

Authors:  Helmut Zarbl; Michael A Gallo; James Glick; Ka Yee Yeung; Paul Vouros
Journal:  Chem Biol Interact       Date:  2010-01-28       Impact factor: 5.192

5.  Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai.

Authors:  G Bruce Copley; A Robert Schnatter; Thomas W Armstrong; Richard D Irons; Min Chen; Xiao Qin Wang; Patrick Kerzic
Journal:  J Occup Environ Med       Date:  2017-04       Impact factor: 2.162

6.  Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.

Authors:  A Robert Schnatter; Deborah C Glass; Gong Tang; Richard D Irons; Lesley Rushton
Journal:  J Natl Cancer Inst       Date:  2012-10-30       Impact factor: 13.506

7.  Benzene and toluene concentrations in a hemodialysis room in a medium sized South Korean city.

Authors:  Moon-Soo Kang; Joong-Rock Hong; Hyo-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong; Yong-Taek Jun; Bu-Soon Son
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 3.165

Review 8.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.